Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FEXT0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,381
Award facts
- Contract value 100% obligated
- $10,381.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,381.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen (0.5 mL) on July 14, 2025, with completion scheduled for July 15, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award was competitively awarded with no set-aside designation and carries a firm fixed price structure. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order for Zepbound (semaglutide), a diabetes and weight management medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The SPE2DX vehicle under which this order was issued serves as a global pharmaceutical support platform enabling flexible procurement of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FEXT0?
SPE2DB25FEXT0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FEXT0 worth?
The government has obligated $10,381 on SPE2DB25FEXT0.
Is contract SPE2DB25FEXT0 an order under another contract?
Yes. SPE2DB25FEXT0 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FEXT0 competed?
The extent of competition for SPE2DB25FEXT0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award